Potential Implications of the Lung Microbiota in Patients with Chronic Obstruction Pulmonary Disease and Non-Small Cell Lung Cancer

Abstract

Recently, chronic obstructive pulmonary disease (COPD) has been considered as a common risk factor of non-small cell lung cancer (NSCLC). However, very few studies have been conducted on the effects of COPD on the lung microbiota in patients with NSCLC. To identify the lung microbiota in patients with COPD and NSCLC (CN), the microbiome of the induced sputa of 90 patients was analyzed using 16S rDNA sequencing. The results showed no significant differences in the bacterial diversities of induced sputa among patients with COPD, NSCLC, and CN and no intrinsic differences among patients with different pathological types of lung cancer. After surgical operation, the diversities of the induced sputa in patients with CN significantly decreased. More remarkably, both the microbial community phenotypes and the components of the induced sputa in patients with CN obviously differed from those in patients with COPD or NSCLC. The relative abundances of Streptococcus, Veillonella, Moraxella, and Actinomyces significantly decreased, but those of Neisseria and Acinetobacter significantly increased in patients with CN compared with those in patients with COPD or NSCLC alone, resulting in increased Gram-negative microbiota and, therefore, in potential pathogenicity and stress tolerance, as well as in enhancement of microbial glycolipid metabolism, amino acid metabolism, and oxidative stress. Although COPD did not affect the number of pulmonary flora species in patients with NSCLC, these significant alterations in the microbial populations, phenotypes, and functions of induced sputa due to COPD would contribute to inflammation-derived cancer progression in patients with CN.

Revealing a causal relationship between gut microbiota and lung cancer: a Mendelian randomization study

“…Specific lung cancer-associated bacteria, such as Prevotella, may impact the tumor microenvironment and initiate a cascade reaction in cancer cells, leading to the upregulation of the PI3K/AKT signaling pathway and cancer development. Overall, this basic research reveals the potential role of Prevotella and other specific lung cancer-associated bacteria in lung cancer development, providing a possible avenue for researching new preventive and therapeutic strategies ( He et al., 2022 ). There is also a study that shows a potential association between Actinomyces and lung cancer development.…”

Promising dawn in tumor microenvironment therapy: engineering oral bacteria

“… 244 The abundance of Actinomyces was found to be significantly decreased after surgical operation in patients with NSCLC (non-small cell lung cancer). 253 Moreover, oral Actinomyces interacted strongly with methylation changes in immune genes, which was associated with patient prognosis. 254 Chua et al 255 conducted a study demonstrating that the increased abundance of Actinobacteria in the gut was associated with heightened immune activation among survivors of acute lymphoblastic leukemia (ALL) who experienced chronic inflammation.…”

Microbial Biosurfactant as an Alternate to Chemical Surfactants for Application in Cosmetics Industries in Personal and Skin Care Products: A Critical Review

“…It was recognized that the microbial communities in many parts of the body are interconnected, including the mouth and the genital tract, and even the gastrointestinal tract and the genitourinary system [ 110 ]. As a result, scientists [ 110 , 111 ] demonstrated that bacteria are able to travel through the digestive tract and exchange ecological habitats with the intestines. Additionally, they found correlations between the vagina and the oral cavity.…”